SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-QSB
(Mark One)
|X| QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 1999
|_| TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT
For the transition period from _______ to ________
Commission file number 0-18109
BCAM INTERNATIONAL, INC.
------------------------
(Exact name of small business issuer as specified in its charter)
New York 13-3228375
- ----------------------------------- ---------------------------------------
(State or other jurisdiction of (I.R.S. Employer Identification No.)
incorporation or organization)
1800 Walt Whitman Road, Melville, New York 11747
- --------------------------------------------------------------------------------
(Address of principal executive offices)
(516) 752-3550
- --------------------------------------------------------------------------------
(Issuer's telephone number)
Not applicable
- --------------------------------------------------------------------------------
(Former name, former address and former fiscal year, if changed
since last report.)
Check whether the issuer (1) filed all reports required to be filed by
Section 13 or 15(d) of the Securities Exchange Act during the past 12 months (or
for such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days.
Yes |X| No |_|
Check whether the registrant filed all documents and reports required to
be filed by Section 12, 13 or 15(d) of the Exchange Act after the distribution
of securities under a plan confirmed by a court. Yes |_| No |_|
State the number of shares outstanding of each of the issuer's classes of
common equity as of the latest practicable date: April 30, 1999: 23,251,116
Transitional Small Business Disclosure Format (check one): Yes |X| No |_|
1
<PAGE>
BCAM INTERNATIONAL, INC.
PART I. FINANCIAL INFORMATION:
Item 1. Financial Statements
Condensed Consolidated Balance Sheet--March 31, 1999 (Unaudited) ........ 3
Condensed Consolidated Statements of Operations - Three Months
ended March 31, 1999 and 1998 (Unaudited) .......................... 4
Condensed Consolidated Statements of Cash Flows - Three months ended
March 31, 1999 and 1998 (Unaudited) ................................. 5
Condensed Consolidated Statement of Shareholders' Equity -
Three months Ended March 31, 1999 (Unaudited) ...................... 6
Notes to Condensed Consolidated Financial Statements - March 31, 1999
(Unaudited) ......................................................... 7
Item 2. Management's Discussion and Analysis or Plan of Operation ........ 16
PART II. OTHER INFORMATION
Item 1. Legal Proceedings ................................................ 18
Item 2. Changes in Securities and Use of Proceeds ........................ 18
Item 4. Submission of matters to a vote of security holders .............. 20
Item 6. Exhibits and Reports on Form 8-K ................................. 20
SIGNATURES ................................................................ 21
INDEX OF EXHIBITS ......................................................... 22
2
<PAGE>
BCAM International, Inc. and subsidiaries
Condensed Consolidated Balance Sheet (Unaudited)
March 31, 1999
<TABLE>
<S> <C>
Assets
Current assets:
Cash and cash equivalents $ 205,000
Prepaid expenses and other current assets 41,000
Assets of discontinued operations 0
------------
Total current assets 246,000
Patent costs and other assets 179,000
------------
Total assets $ 425,000
============
Liabilities and shareholders' equity
Current liabilities:
Current portion of long term debt $ 75,000
Accounts payable 271,000
Accrued expenses and other current liabilities 368,000
Liabilities of discontinued operations 125,000
------------
Total current liabilities 839,000
------------
Commitments and contingencies (Note 7)
Shareholders' equity
Acquisition preferred stock, par value $.01 per share:
750,000 shares authorized, none issued --
Preferred stock, 2,000,000 shares authorized, none issued --
Common stock, par value $.01 per share; authorized 65,000,000
Shares, 24,014,298 shares issued and 23,251,116 shares
Outstanding, see Note 5 241,000
Additional paid-in capital 30,103,000
Deficit (29,859,000)
------------
485,000
Less: 763,182 treasury shares (899,000)
------------
(414,000)
------------
Total liabilities and shareholders' equity $ 425,000
============
</TABLE>
See accompanying notes
3
<PAGE>
BCAM International, Inc. and subsidiaries
Condensed Consolidated Statements of Operations
For the three months ended March 31, 1999 and 1998
1999 1998
------------ ------------
License revenue $ 0 $ 2,000
------------ ------------
Costs and expenses:
Selling, general and administrative 228,000 568,000
Charge for compensatory element of
1997 options approved in 1998 0 858,000
Research & development 45,000 124,000
------------ ------------
273,000 1,550,000
------------ ------------
Loss from operations (273,000) (1,548,000)
Interest and other income (expense) (2,000) 12,000
------------ ------------
Loss from continuing operations (275,000) (1,536,000)
------------ ------------
Discontinued operations - Drew, operations
through September 1998 0 (1,844,000)
Discontinued operations - Drew, gain on
sale of 33.3% interest, net of 33.3%
of Drew's losses 997,000 0
------------ ------------
Subtotal - Drew 997,000 (1,844,000)
Discontinued operations - HCAD and ECSD,
Including estimated loss on disposal of
HCAD of approximately $250,000 in 1998 0 (803,000)
------------ ------------
Income (loss) from discontinued operations 997,000 (2,647,000)
------------ ------------
Net income (loss) $ 722,000 $ (4,183,000)
============ ============
Basic net loss per share:
Continuing operations $ (0.01) $ (0.09)
Discontinued operations $ 0.04 $ (0.15)
------------ ------------
Net loss $ 0.03 $ (0.24)
============ ============
Weighted average number of common
Shares outstanding (see Note 6) 22,573,000 17,720,000
============ ============
See accompanying notes
4
<PAGE>
BCAM International, Inc. and subsidiaries
Condensed Consolidated Statements of Cash Flows (Unaudited)
<TABLE>
<CAPTION>
Three months ended March 30
--------------------------
1999 1998
----------- -----------
<S> <C> <C>
Operating activities
Net income (loss) $ 722,000 $(4,183,000)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization 10,000 90,000
Amortization of unamortized charge for beneficial debt conversion 0 1,493,000
Amortization of deferred finance cost and debt discount 28,000 135,000
Compensation charge for stock options including $286,000
related to discontinued operations 0 1,144,000
Interest paid in kind 0 390,000
Non-cash gain on sale of Drew (997,000)
Changes in operating assets and liabilities:
Accounts receivable 0 (238,000)
Inventory 0 (592,000)
All other current assets 6,000 (91,000)
Accounts payable, accrued expenses, current liabilities, other 37,000 894,000
All other, net 0 51,000
----------- -----------
Net cash (used in) operating activities (194,000) (907,000)
----------- -----------
Investing activities
Purchase of equipment and software technology 0 (130,000)
----------- -----------
Net cash (used in) provided by investing activities 0 (130,000)
----------- -----------
Financing activities
Payment of notes payable and long term debt 0 (72,000)
Drawdown (payment) of revolving credit agreement 0 171,000
Payment of stock registration and issuance, proxy and Drew sale costs (139,000) 0
----------- -----------
Net cash provided (used) by financing activities (139,000) 99,000
----------- -----------
(Decrease) increase in cash and cash equivalents (333,000) 938,000
Cash and cash equivalents at beginning of period 538,000 1,594,000
----------- -----------
Cash and cash equivalents at end of period $ 205,000 $ 656,000
=========== ===========
</TABLE>
See accompanying notes
5
<PAGE>
BCAM International Inc. and subsidiaries
Condensed Consolidated Statement of Shareholders' Equity
<TABLE>
<CAPTION>
Common Stock $.01 par
value
Paid-in
Shares Amount Surplus Deficit Subtotal
-------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C>
Balance at January 1, 1998 21,754,471 $ 218,000 $ 30,126,000 $(30,581,000) $ (237,000)
Shares issued in "repricing" increment of
April 1998 offering 2,259,827 23,000 (23,000) -- --
Net income -- -- -- 722,000 722,000
-------------------------------------------------------------------------------
Balance at March 31, 1999 24,019,298(a) $ 241,000 $ 30,103,000 (29,859,000) 485,000
===============================================================================
<CAPTION>
Treasury
Stock Total
-----------------------------
<S> <C> <C>
Balance at January 1, 1998 $ (899,000) $ (1,136,000)
Shares issued in "repricing" increment of
April 1998 offering -- --
Net income -- 722,000
-----------------------------
Balance at March 31, 1999 $ (899,000) (414,000)
=============================
</TABLE>
(a) Excludes additional shares issuable, without additional consideration,
pursuant to "repricing" provisions of the April 1998 offering of common stock
and warrants. See Note 5.
6
<PAGE>
BCAM International, Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Unaudited)
March 31, 1999
1. Basis of Presentation
The accompanying unaudited condensed consolidated financial statements
have been prepared in accordance with generally accepted accounting principles
for interim financial information and with the instructions to Form 10-QSB.
Accordingly, they do not include all of the information and footnotes required
by generally accepted accounting principles for complete financial statements.
In the opinion of management, all adjustments (consisting of normal recurring
adjustments and accruals) considered necessary for a fair presentation have been
included. See Form 10-KSB for the year ended December 31, 1998 for more
information.
2. Description of Business, Principles of Consolidation, Going Concern
Consideration
BCAM International, Inc. and subsidiaries (the "Company") has been
primarily a software, technology and consulting company, specializing in
providing ergonomic solutions (human factors engineering) to individuals,
corporations and government. The Company's revenues had historically been
derived primarily from ergonomic consulting services. Through a series of
actions since approximately September 1997 including the acquisition of 100% of
Drew Shoe Corporation ("Drew"), subsequent disposition of 100% of Drew and
certain other restructuring activities (which are summarized in the following
paragraph and described in more detail in Notes 3 and 5 to the Company's annual
Consolidated Financial Statements included with Form 10-KSB for the year ended
December 31, 1998), the Company is now a technology pioneer in the field of
Intelligent Surface Technology ("IST") blending biomechanics and ergonomics with
innovative electronic systems and software.
The acquisition and restructuring activity since approximately September
1997 has included the following. On September 22, 1997, the Company acquired
Drew as described in Note 4 to the Consolidated Financial Statements contained
in Form 10-KSB for the year ended December 31, 1998. Drew is a manufacturer,
marketer and distributor of medical footwear. The purchase of Drew was financed
principally by the issuance of 10%/13% Convertible Notes and Warrants. In
December 1997 the Board of Directors of the Company decided to sell the
operations of the Ergonomic Consulting Services Division ("ECSD") due to the
inability of that business to generate operating profits for the Company as
discussed further in Note 6. In February 1998, the Board of Directors of the
Company decided to discontinue the HumanCAD Systems Operations ("HCAD") as a
result of the lack of available financing, on acceptable terms to the Company,
to further the necessary business development activities of that operation as
discussed further in Note 6. In April 1998 the Company restructured the 10%/13%
Convertible Notes which included granting a 10% interest in the common stock of
Drew (and also 10% of the common stock of another subsidiary, BCAM Technologies,
Inc.) to the noteholders as further discussed in Note 5. In October 1998, the
Company sold 56.7% of Drew to the holder of the 10%/13% Convertible Notes and on
March 4, 1999 it sold its remaining 33.3% interest in the common stock of Drew,
after receipt of approval of the shareholders of the Company as discussed
further in Note 3.
The results of operations for the three month periods ended March 31, 1999
and 1998 reflect the results of operations of Drew as a discontinued operation
with a measurement date of October 2, 1998.
The consolidated financial statements include the accounts of BCAM
International, Inc. and its subsidiaries, principally BCAM Technologies, Inc.
(principally IST and related technologies).
7
<PAGE>
Results of operations for the three month period ended March 31, 1999 are
not necessarily indicative of results of operations to be expected for the year
ending December 31, 1999. Further, the three months ended March 31, 1999 include
a one-time, non-cash gain on the sale of Drew.
Going Concern Consideration - As indicated in the accompanying
consolidated financial statements, as of March 31, 1999, the Company had
negative working capital of approximately ($595,000) and negative net worth of
approximately ($414,000), and for the three months then ended had losses from
continuing operations of approximately ($275,000) with no revenues. The Company
has a development agenda which requires additional financing. Losses from
continuing operations have continued since March 31, 1999. These factors, among
others, indicate that the Company is in need of significant additional financing
and/or a strategic business arrangement in order to continue its operations
through the 1999 fiscal year. The Company believes that its cash resources at
March 31, 1999 are insufficient to fund its operations through the second
quarter of 1999, assuming it receives the cooperation of its creditors, and it
will be required to raise additional capital or enter into a strategic business
arrangement in order to continue its planned operations.
The Company's plans include undertaking a development program to
miniaturize and lower the cost of IST applications in the belief that the result
will be a more marketable product than the current IST application. The
development and subsequent marketing is a multi-year project. In order to
miniaturize and lower the cost of IST applications, the Company and MCNC
(founded in 1980 as the Microelectronics Center of North Carolina and now known
simply as MCNC) have completed an alpha prototype of a microvalve component to
control air flow in the IST system. A beta (production ready) version of the
MCNC microvalve would be the subject of further development about which the
Company and MCNC have entered into a non-binding letter of intent. The Company's
ability to perform such further development will be dependent upon its ability
to obtain sufficient financial resources or its ability to enter into a
strategic transaction which would provide the Company the resources to perform
such development. Such further development would involve costs incurred under
arrangements with MCNC as well as costs incurred by the Company. Beyond
development, the Company would require capital to commercialize, market and
sell. The Company's plans are to raise additional financing or enter into a
strategic transaction in order to proceed with the development program. At the
present time, the Company is in discussion with potential sources of additional
financing and with potential candidates for a strategic transaction. No
assurance can be made that such discussions would result in definitive
arrangements. These factors, among others, indicate that in the absence of
additional financing or a strategic business arrangement, the Company does not
have the financial resources to go forward with such further development and to
continue as a going concern.
There can be no assurances that management's plans described in the
preceding paragraph will be realized. The accompanying Consolidated Financial
Statements do not include any adjustments related to the recoverability and
classification of assets or the amounts and classification of liabilities that
might be necessary should the Company be unable to continue operations as a
going concern.
For further information, refer to the audited consolidated financial
statements and related notes thereto of the Company (at December 31, 1998 and
for the two year periods then ended) included in the Company's annual report on
Form 10-KSB for the year ended December 31, 1998 and the Form 8-K filed by the
Company on November 6, 1998.
3. Sale of Drew -
During the quarter ended March 31, 1999, the Company completed the sale of
Drew.
On October 2, 1998, the Board of Directors of the Company approved a plan
to dispose of the Company's interest in Drew (the "Plan"). Pursuant to the Plan,
on October 23, 1998, the Company entered into a Stock Purchase and Restructure
Agreement with Impleo, LLC. ("Impleo") and sold 56.7% of the outstanding shares
of its Drew subsidiary to Impleo in exchange for approximately $3,780,000
principal amount of the Company's 10%/13% Secured Convertible Notes ("Notes").
Impleo, which initially owned $5,000,000 principal amount of Notes, purchased
the remaining $1,000,000 principal amount (plus accrued interest) of Notes on
October 23, 1998, thereby making it the sole holder of the
8
<PAGE>
Notes. After this transaction, the remaining principal balance on the
Convertible Notes was $2,220,000 plus accrued interest which aggregated
approximately $1,025,000 (including approximately $805,000 paid-in-kind and
approximately $220,000 accrued) as of March 4, 1999 when the remaining 33.3% was
sold. The Notes were secured by all of the assets of the Company and were due in
April 1999. In April 1998, the Company had granted Impleo and the other holders
of the 10%/13% convertible notes an aggregate 10% ownership interest in Drew.
The Company entered into a separate Purchase and Sale Agreement on October 23,
1998 with Impleo in which it agreed to promptly submit to its shareholders a
proposal to sell the remaining 33.3% of Drew to Impleo in exchange for the
cancellation of the then remaining principal amount of Notes together with
accrued interest thereon (the "Second Sale"). On March 4, 1999, at a Special
Meeting of Shareholders, the sale of the remaining 33.3% of Drew was approved by
the shareholders and such remaining interest was sold.
As a condition of the sale of the Drew shares to, and the redemption of
the Notes from, Impleo, Michael Strauss, the Chairman, President and Chief
Executive Officer of the Company, has become the Chief Executive Officer of
Drew. Mr. Strauss is obliged to spend a defined amount of his time on the
business of Drew. Mr. Strauss will continue to serve the Company as its
Chairman, President and Chief Executive Officer and has entered into a new
employment agreement with the Company that reduces his compensation from the
Company and requires him to spend a defined amount of his time on the Company's
business.
Because the Company's intention was to divest itself of its entire
interest in Drew pursuant to the Plan, the Company has accounted for Drew as a
discontinued operation with a measurement date of October 2, 1998. Accordingly,
the Company reflected Drew's operations (which had been consolidated prior to
that date) and the gain from the sale of the 33.3% as separate components of
discontinued operations in the accompanying Condensed Consolidated Statements of
Operations. The Company has been informed by Drew that Drew's operations for the
remainder of 1998 (October through December) and for the period until its
ultimate sale on March 4, 1999, were expected to generate material losses. The
Company's proportionate share of such losses would likely be material. Generally
accepted accounting principles, as reflected in Emerging Issues Task Force Issue
85-36, indicate that such operating losses should not be recorded when the sale
transaction will generate a gain, after considering such losses, since the
recognition of losses in one period will generate a gain in the next. The
Company did report a non-cash gain of approximately $997,000 on the March 4,
1999 sale of the 33.3% interest in Drew after reflecting 33.3% share of Drew's
losses from operations from October 1998 through March 4, 1999 (which the
Company believes, based on information provided by Drew, to be in excess of
approximately $400,000) and costs of disposal.
Impleo is an affiliate of Wexford Management, LLP.
In connection with the sale and redemption transaction, the Company has
been released from its guarantee of approximately $3,800,000 of secured
obligations of Drew to a bank.
Separately, the Company and Drew, under the Plan, have reached agreement
with the sellers of Drew to the Company in 1997 to: (i) cancel an employment
contract and enter into a severance agreement with the former president of Drew
(to be paid by Drew), (ii) cancel approximately $200,000 of notes payable by the
Company to the former owners of Drew, (iii) forgive certain purchase price
adjustments due to the Company from the former owners of Drew and the
assumption, by Drew, of certain contingent liabilities in connection with the
Ulin & Holland litigation (such litigation is discussed in Note 8).
Also see Note 8 regarding a shareholder derivative action commenced in
February 1999 regarding this matter.
For selected balance sheet information at September 30, 1998 (unaudited)
and the results of operations for the nine months ended September 30, 1998
(unaudited) and for the period from September 23, 1997 (date of acquisition) to
December 31, 1997 for Drew, the reader is
9
<PAGE>
referred to the Form 10-KSB for the year ended December 31, 1998. For
information regarding the purchase of Drew, the reader is referred to Note 4 to
Consolidated Financial Statements as of and for the year ended December 31, 1998
included in Form 10-KSB for the year ended December 31, 1998.
4. Long Term Debt and Convertible Notes
Secured 10%/13% Convertible Notes and Warrants - In order to fund
the acquisition of Drew and provide working capital to the Company, on September
19, 1997, the Company issued convertible notes (the "Convertible Notes"), and
Non-Redeemable Class DD Warrants to purchase 2,400,000 shares of common stock of
the Company at $1.75 (subject to the operation of certain antidilution
provisions) prior to September 19, 2002, in the aggregate amount of $6,000,000.
The Convertible Notes bore an interest rate of 10%, payable semi-annually, but
the Company, at its discretion, could pay interest in the form of additional
Convertible Notes ("payment-in-kind") in which case the annual interest rate
became 13% with semi-annual compounding. The Convertible Notes required the
Company to maintain compliance with certain financial covenants including
maintenance of minimum levels of interest coverage and net worth (as defined).
At December 31, 1997, the Company was in violation of such covenants and the
Convertible Notes were subsequently restructured as described in the second
succeeding paragraph. On March 19, 1998 and on September 19, 1998, the Company
elected to make the semiannual interest payment in kind. As such, the Company
increased the related obligation under the Convertible Notes to $6,805,350.
The Convertible Notes were due, as amended (see below), on April 16,
1999, unless at any time after September 19, 1998 they were converted, as
amended, at $.80 per share, into 7,500,000 shares of Common Stock of the Company
(subject to the operation of antidilution provisions to certain transactions
including the April 1998 financing described in Note 6 and related "repricings"
and other potential financings).
On April 14, 1998, the noteholders and the Company entered into the
First Amendment of the Note Purchase Agreement (together with a Stock Pledge
Agreement and Security Agreement) in order to restructure the obligation. The
key elements of the restructuring were as follows: (1) waiving of the Company's
violations of the financial covenants at December 31, 1997 (as well as certain
other breaches of the agreement), (2) eliminating the financial covenants
through April 16, 1999, (3) securing the obligation with a pledge of all of the
assets of the Company (excluding the assets of Drew which are already pledged to
a bank), including the stock of the Company's subsidiaries, (4) accelerating the
maturity date for the obligation from September 19, 2002 to April 16, 1999, (5)
cancellation of Class DD warrants to purchase 400,000 shares of common stock of
the Company, (6) issuance to the holders of a total of 10% of the common shares
of the Company's subsidiaries, Drew Shoe Corporation and BCAM Technologies, Inc.
As a result of the restructuring, the Company had a significant capital
requirement to repay this obligation ($6,805,350 including interest "paid in
kind" on March 19, 1998 and September 19, 1998, respectively, and before
additional interest payments in cash or in kind subsequent to that date) by
April 19, 1999 or face default and foreclosure on the security. The Company's
intention was to refinance or otherwise restructure this obligation prior to its
maturity.
During 1998 the Company reflected an aggregate of approximately
$2,500,000 of charges to operations and/or stockholders' equity in connection
with the restructuring of the debt. Such charges included: (i) approximately
$1,651,000 to write-off interest and finance costs as further described in the
second following paragraph, (ii) approximately $552,000 charged to extraordinary
item representing the approximate value of the 10% interest in subsidiaries
given up and (iii) approximately $281,000 charged to shareholders' equity
representing the unamortized portion of the amounts assigned to the value of the
400,000 Class DD warrants given up by the holders of the Convertible Notes.
As discussed in Note 3, on October 23, 1998, the Company agreed with
the holders of the Convertible Notes to redeem $3,780,000 principal amount of
Convertible Notes in exchange for 56.7% of the common stock of Drew. Further,
the parties agreed that the Company would request shareholder approval to redeem
the remaining approximately $2,220,000 principal amount of Convertible Notes
together with paid-in-kind and accrued interest in exchange for the remaining
33.3% of the common stock of Drew owned by the Company. On March 4, 1999, at a
Special Meeting of Shareholders, the proposal
10
<PAGE>
to sell the remaining 33.3% interest in Drew was approved by the shareholders
and this remaining 33.3% interest in Drew was sold.
The Company originally recorded approximately $1,872,000 of the $6,000,000
received from the sale of the Convertible Notes and Warrants as the estimated
value (based upon a "Black Scholes" calculation) of the detachable warrants
issued in connection with the Convertible Notes resulting in a discount to the
value assigned to the Convertible Notes. Additionally, the Company originally
recorded approximately $825,000 in deferred financing costs in connection with
the issuance of the Convertible Notes. The approximately $1,872,000 in debt
discount and $825,000 of deferred finance costs were being charged to interest
and financing costs over the original 60 month term of the Convertible Notes. As
discussed above, in April 1998, the Company and the holders of the Convertible
Notes agreed to shorten the maturity of the Convertible Notes from September
2002 to April 1999. Under generally accepted accounting principles the Company
recorded a charge to interest and financing costs during 1998 for the
amortization of this discount and these costs that would have occurred during
the 41 months that have been shortened from the original maturity ($1,651,000).
The private placement of convertible notes and warrants to one investor
group (aggregating $5,000,000 of the total $6,000,000) was made with the
assistance of an investment banker who charged a cash fee of 6% ($300,000) plus
187,500 unregistered shares of common stock (valued at $1.20 per share to
reflect a discount for lack of registration), and Class EE warrants to purchase
500,000 shares of common stock at an exercise price of $0.80 per share, of the
Company. The cash fee, shares of stock and the estimated fair value of the
warrants aggregate approximately $1,025,000. This amount has been apportioned
between deferred financing costs (discussed in the preceding paragraph), and
acquisition costs of Drew. The portion allocated to deferred financing costs
(approximately $775,000), together with legal and other costs of the transaction
were being amortized over the term of the Convertible Notes. There were no
investment banking fees associated with the remaining $1,000,000 of proceeds.
Remaining debt discount and deferred financing costs in connection with
the transaction were amortized over the remaining term of the Convertible Notes.
The market value of the Company's common stock on The Nasdaq SmallCap
Market on September 19, 1997 was approximately $1.50 at the inception of the
Notes and approximately $1.25 and $0.25 at March 19, 1998 and September 19,
1998, respectively, (when additional Convertible Notes were issued as
payment-in-kind for interest).
In response to positions taken by the Securities and Exchange Commission,
Emerging Issues Task Force Statement D-60 has been issued. Statement D-60
requires certain accounting for securities issued which are convertible into
common stock at a value which is "beneficial" at the date of issuance (such as
the Convertible Notes). This accounting required that the beneficial value be
charged to operations (based upon the traded market price, without discount,
compared to the conversion price) in the case of a convertible note, over a
period reflecting the shortest period in which the investor had to exercise and
under the most favorable terms to the investor. As such, the Company has charged
approximately $5,925,000 at September 19, 1997, an additional $219,000 at March
19, 1998 and no additional amount at September 19, 1998, to Unamortized Charge
for Beneficial Debt Conversion in the shareholders' equity section of its
Consolidated Balance Sheet. Such amounts represent the value of the beneficial
debt conversion feature of the Convertible Notes measured at the date of
issuance in September 1997 and for the payment-in-kind in March 1998. These
amounts were charged to Interest and financing costs of discontinued operations
in the Condensed Consolidated Statements of Operations for approximately $-0-
and $1,591,000, respectively, during the three months ended March 31, 1999 and
1998.
In connection with the sale of 56.7% of the common stock of Drew and the
redemption of $3,780,000 of 10%/13% Convertible Notes in October 1998, the
Company was released from its guarantee of the term loan and revolving credit
obligations of Drew. Additionally, the Company has been released from liability
for the $200,000 balloon payment to the sellers of Drew due on September 19,
1999.
11
<PAGE>
At March 31, 1999, the obligation under the 10%/13% Convertible Notes was
satisfied, and the remaining warrants were cancelled, by the sale of the
Company's remaining 33.3% interest in Drew to the Noteholder.
Long-term debt at March 31, 1999 (payable in 1999 and therefore classified
as a current liability in the accompanying Condensed Consolidated Balance Sheet)
consists of $75,000 of notes payable to the sellers of Drew, bearing interest at
8% with monthly payments of principal aggregating $8,333 plus interest. In
February 1999, the Company advised the holders of the seller notes that the
January 1999 monthly payment of principal and interest would not be made and
that future monthly payments would similarly not be made until and unless the
Company obtained new financing. Such notes are therefore in arrears at March 31,
1999. The Company requested the Noteholders' forbearance and there is no
assurance that the holders of the seller notes will not take action against the
Company to collect their notes.
5. Private Placement of equity during 1998, subject to "repricing"
Beginning on April 14, 1998, the Company commenced a private offering of
its common stock and warrants. The offering generated aggregate proceeds of
$2,000,000 from the purchase of 1,980,198 shares of common stock of the Company
subject to "repricing", as described below, and warrants to purchase 250,000
shares of common stock at $2.05 for three years by seven accredited investors.
The Company has agreed to, and did, register such shares.
The number of shares issuable to these investors were to be "repriced"
pursuant to a schedule in two $300,000 increments and then in seven $200,000
increments on nine occasions commencing with the effectiveness of a registration
statement (August 13, 1998) covering up to 4,000,000 additional shares and again
60 days later and then in 30 day intervals. On such dates, the investor would
receive the additional number of shares, if any, that result from the difference
between the number of shares actually issued and the number of shares which
would have been issued using a 23% discount to the market price, as defined, at
that time. The operation of this provision could result in significantly greater
number of shares being issued. The Company paid a placement agent a fee of 6.5%
with respect to this transaction.
In August 1998, 436,047 shares were issued in connection with the
"repricing" provisions and very significant additional shares (estimated to be
in excess of 5,000,000 shares) would be required to be issued for the October,
November and December 1998 "repricing" dates.
On December 24, 1998, the Company and the investors agreed to amend the
subscription agreement with respect to "repricing". The December 24, 1998
amendment has four principal effects as follows: (i) the August, October,
November and December 1998 "repricings" are eliminated in favor of new
"repricings" which began on January 1, 1999, (ii) the discount from market used
to measure the "repricings" was increased from 23% to 27% (iii) a ceiling price
was established of $0.75 per share and (iv) certain penalties under the
agreement were waived. Under the amended agreement, the investors, at their
option, may reprice up to 12 1/2% of the amount invested (an aggregate of
$250,000 based upon the original $2,000,000 invested in April 1998) on the first
of each month beginning with January 1, 1999. Any amounts not "repriced" in any
month may be carried over to any future month without limitation.
In connection with the amendment, the Company was obliged to issue
additional shares to the investors to bring the total shares from 1,980,198
originally purchased up to 2,666,667 shares (inclusive of the 436,047 shares
issued in August 1998 as discussed in the preceding paragraph) based upon the
$0.75 ceiling price in the amendment. Additionally, these investors requested a
"repricing" of $190,000 of the offering in January 1999. The obligation to issue
shares to reflect the new ceiling and the January 1999 repricing increment
resulted in the issuance to the investors of an additional 2,259,827 shares on
January 27, 1999.
Of the total dollar amount of the offering, only the $190,000 (referred to
in the preceding paragraph) of the $2,000,000 proceeds of the offering has been
"repriced" leaving $1,810,000 still to be "repriced" at the holders' option. The
"repricing" of this amount ($1,810,000), if requested by the
12
<PAGE>
investors, at market prices for the Company's stock in March 1999 would result
in a very significant number of additional shares being issued and in a change
of control of the Company to these investors. The Company is in discussions with
the representatives of the investors to restructure the "repricing" provisions
in light of the very significant effects that would result at current prices of
the Company's common stock.
The Company is exposed to significant penalties for failure to file a
registration statement covering additional shares with respect to possible
"repricings" by April 15, 1999 (which registration statement was not filed by
the Company) and to have such registration statement declared effective prior to
July 31, 1999 and has agreed not to issue certain financings. As a practical
matter, the Company expects that it will be unable to file such registration
statements any time soon until the financial and liquidity concerns discussed in
Note 1 are resolved, if at all. As such, the Company is attempting to
renegotiate such penalties also. If it is not successful, such penalties will
begin to accrue in April 1999.
6. Other Discontinued Operations
Ergonomic Consulting Services Division - In December 1997, the Board of
Directors of the Company approved a plan to sell the operations of its Ergonomic
Consulting Services Division ("ECSD"). ECSD had not generated operating profits
and was no longer considered a core asset in light of the Company's strategy.
The plan of disposition involved finding a strategic buyer who would take over
the Company's contractual commitments (some of which are long-term) to
consulting division customers and liquidating the remaining assets through
collection (with respect to receivables) or sale or disposal (with respect to
furniture and equipment). On February 9, 1998, the Company closed on the sale of
the revenue contract rights and transfer of the obligations for certain related
personnel of the ECSD to a third party. Terms of the sale call for the payment
of a portion of future revenues of the contracts sold as well as a portion of
certain follow-on work, or referrals for work provided by the Company. At March
31, 1999, there were no material assets or liabilities of the ECSD. The
operations of the ECSD from January 1, 1998 through disposal on February 9, 1998
did not generate a loss due to the high utilization of personnel on contracts
during that time. Approximately $50,000 was accrued in the December 31, 1997
financial statements as a loss on disposal representing management's estimate of
the write-off of furniture and equipment and accrual of certain lease costs.
There was no material severance paid in connection with the discontinuance of
the ECSD.
There were not material royalties from the sale of ECSD in the three
months ended March 31, 1999 or 1998.
HumanCAD Systems Operations - During late February 1998, as a result of
specific events at the time, the Board of Directors of the Company approved a
plan to seek alternative value for the HumanCAD Systems operations ("HCAD") by:
(i) initially reducing the activity and (ii) seeking a strategic or management
buyer for the operation.
In December 1997, the Company had reached preliminary agreement with a
funding source to provide approximately $2,500,000 for development and marketing
of the Company's existing and planned HCAD ergonomic modeling software products.
In January 1998, the Company commenced executing the business plan contemplated
by the financing but in late February 1998, the funding source advised the
Company that they were no longer willing to go forward with the planned
financing. The Company was unsuccessful in seeking a strategic or possible
management buyer for a majority of HCAD on a basis which would result in
meaningful value for the shareholders and therefore, in October 1998, placed the
operations of HCAD in receivership under the bankruptcy laws of Ontario, Canada,
where HCAD was headquartered.
(a) The measurement date for the discontinuance was February 1998, at which
time losses from January 1, 1998 through February 1998 were recorded and a
provision (approximately $250,000) for discontinued operations
(principally severance and non-cancelable lease costs) was made. Such
amount aggregated approximately $803,000. At March 31, 1999, assets of the
HCAD were approximately $0 and liabilities were approximately $100,000
consisting principally of trade payables.
13
<PAGE>
The provision for discontinued operations consists principally of payroll
and other costs associated with the effort to discontinue, the write off of
inventories and other assets dedicated to HCAD and severance principally for the
former HCAD President. At March 31, 1999, substantially all of such costs have
been incurred and the remaining accrual is not material.
7. Contingencies
In January 1998, Ulin & Holland Incorporated ("U & H") filed suit against
the Company's then subsidiary, Drew, in United States District Court for the
District of Massachusetts. The suit alleges that U & H was retained in 1992 by
Drew pursuant to which U & H alleges that it is due a fee of not less than
$297,000 in connection with the Company's acquisition of Drew. Drew disputes
this claim. U & H has named the Company as a defendant in this lawsuit.
Subsequent to the Company's divestiture of the majority ownership of Drew, Drew
is responsible for the defense of this matter. In March 1999, the Company was
notified that it is no longer a defendant in that lawsuit.
On or about February 22, 1999, a shareholder derivative action was filed
in United States District Court for the Eastern District of New York in
connection with certain transactions culminating in the sale by the Company to
Impleo, LLC of the Company's interest in Drew. The complaint names all of the
Company's current directors and several former directors as defendants as well
as Impleo, LLC and certain related entities and individuals (collectively, the
"Defendants"). The allegations contained in the complaint challenge the
Defendants' actions in connection with certain transactions, including but not
limited to, (i) the April 14, 1998 restructuring of certain convertible notes;
(ii) the October 1998 sale of 56.7% of Drew to Impleo, LLC; and (iii) the sale
on March 4, 1999 to Impleo, LLC of the Company's remaining 33.3% interest in the
Drew. In addition to seeking recovery on behalf of the Company for certain
allegedly wrongful acts on the part of the Defendants, the complaint seeks,
among other things, to enjoin or set aside any shareholder vote in connection
with a proxy statement filed with the SEC on or about February 1, 1999 pursuant
to which the Company received approval of over 67% of its shareholders to sell
its remaining 33.3% interest in Drew and to block or rescind the sale of any
interests in Drew to Impleo, LLC. The current Directors deny the allegations
concerning any allegedly wrongful actions. The Company intends to answer the
complaint during May 1999.
In October 1998, the Company's HumanCAD Systems Inc. subsidiary filed an
assignment in bankruptcy under the laws of the Province of Ontario, Canada and
Fuller Landau Ltd., 151 Bloor St. West, Toronto, Canada, was appointed receiver
and trustee. Certain creditors of the HumanCAD operations have filed or
threatened to file claims against the Company for the debts of HumanCAD. One
such action was filed by Miller Freeman, Inc. in the Civil Court of City of New
York in the amount of approximately $18,000. The Company intends to vigorously
defend itself in such action, however its ability to do so may be limited by its
financial resources which are currently inadequate (See Form 10-KSB for the year
ended December 31, 1998 including; Consolidated Financial Statements, Report of
Independent Public Accountants and Management's Discussion and Analysis or Plan
of Operations).
The Company has an employment agreement with its CEO which call for
significant payments in the event of a change of control of the Company.
Also see Note 5.
8. Other -
Per share data - In March 1997, the Financial Accounting Standards Board
("FASB") issued Statement of Financial Standards ("SFAS") No. 128, Earnings per
Share. Statement 128 replaced the calculation of primary and fully diluted
earnings per share with basic and diluted earnings per share. Unlike primary
earnings per share, basic earnings per share excludes any dilutive effects of
options, warrants and convertible securities. Diluted earnings per share is very
similar to the previously reported fully diluted earnings per share. Net loss
per share has been computed on the basis of the weighted average number of
common shares outstanding. Common stock equivalents have been excluded because
their effect is antidilutive.
14
<PAGE>
Income taxes - The Company accounts for income taxes in accordance with
Financial Accounting Standards Board ("FASB") Statement No. 109, "Accounting for
Income Taxes". The Company has not reflected a credit for income taxes in the
accompanying Condensed Consolidated Statements of Operations for the three
months ended March 31, 1999 and 1998, since the future availability of net
operating loss carryforwards have been offset in full by valuation allowances in
accordance with FASB Statement No. 109.
Other - See Note 11 to Consolidated financial statements at December 31,
1997 included in Form 10-KSB for the year ended December 31, 1998 regarding
charges to fourth quarter operations in 1997.
15
<PAGE>
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATIONS
Except for the historical information contained herein, the following discussion
contains forward looking statements that involve risk and uncertainties. The
Company's actual results could differ materially from those discussed herein.
Factors that could cause or contribute to such differences include, but are not
limited to, those discussed below in Factors That May Affect Future Results
Overview
BCAM International, Inc. and subsidiaries (the "Company") has been
primarily a software, technology and consulting company, specializing in
providing ergonomic solutions (human factors engineering) to individuals,
corporations and government. The Company's revenues had historically been
derived primarily from ergonomic consulting services. Through a series of
actions since approximately September 1997 including the acquisition of 100% of
Drew Shoe Corporation ("Drew"), subsequent disposition of 100% of Drew and
certain other restructuring activities (which are summarized in the following
paragraph and described in more detail in Notes 3 and 5 to the Company's annual
Consolidated Financial Statements included with Form 10-KSB for the year ended
December 31, 1998), the Company is now a technology pioneer in the field of
Intelligent Surface Technology ("IST") blending biomechanics and ergonomics with
innovative electronic systems and software.
The acquisition and restructuring activity since approximately September
1997 has included the following. On September 22, 1997, the Company acquired
Drew as described in Note 4 to the Consolidated Financial Statements contained
in Form 10-KSB for the year ended December 31, 1998. Drew is a manufacturer,
marketer and distributor of medical footwear. The purchase of Drew was financed
principally by the issuance of 10%/13% Convertible Notes and Warrants. In
December 1997 the Board of Directors of the Company decided to sell the
operations of the Ergonomic Consulting Services Division ("ECSD") due to the
inability of that business to generate operating profits for the Company as
discussed further in Note 6. In February 1998, the Board of Directors of the
Company decided to discontinue the HumanCAD Systems Operations ("HCAD") as a
result of the lack of available financing, on acceptable terms to the Company,
to further the necessary business development activities of that operation as
discussed further in Note 6. In April 1998 the Company restructured the 10%/13%
Convertible Notes which included granting a 10% interest in the common stock of
Drew (and also 10% of the common stock of another subsidiary, BCAM Technologies,
Inc.) to the noteholders as further discussed in Note 5. In October 1998, the
Company sold 56.7% of Drew to the holder of the 10%/13% Convertible Notes and on
March 4, 1999 it sold its remaining 33.3% interest in the common stock of Drew,
after receipt of approval of the shareholders of the Company as discussed
further in Note 3.
The Company is now in discussions with others regarding potential
financing and/or strategic transaction(s) for the Company going forward.
Results of Operations
Results of operations for the three months ended March 31, 1999 and 1998
were significantly impacted by restructuring developments including: (1) the
sale of the Company's remaining 33.3% interest in Drew to the holders of the
10%/13% Convertible Notes ("Notes") in exchange for redemption of the remaining
Notes and related interest (see Note 3 to Condensed Consolidated Financial
Statements), (2) the sale of the ECSD (in February 1998) and the measurement
date for discontinuance of the HCAD operations (February 1998), (3) a charge to
compensation expense in the first quarter of 1998 for certain options granted
during 1997 which were at exercise prices below the market value when approved
by the shareholders in February 1998, and (4) charges and costs, in the first
quarter of 1998, related to the financing to acquire Drew.
Discontinued operations - As discussed in greater detail in Notes 3 and 6
to the Condensed Consolidated Financial Statements, the Company has recorded the
operations of Drew, ECSD and HCAD as discontinued operations. Operations of
these discontinued businesses in the three months ended March
16
<PAGE>
31, 1998 (including provisions for losses on discontinuance of HCAD of
approximately $250,000) resulted in losses of approximately $2,647,000 including
very substantial non-cash charges. Such non-cash charges included charges for
the beneficial conversion feature of certain convertible notes (principally used
for the Drew acquisition) pursuant to Emerging Issues Task Force Statement #
D-60 of approximately $1,493,000 and a charge for approximately $286,000
(related to HCAD) for the compensatory element of stock options granted in 1997
and approved by the shareholders in the three months ended March 31, 1998.
Additionally, in the three months ended March 31, 1998, the following other
charges and costs related to the Drew acquisition are included in results of
discontinued operations: (i) amortization of debt discount and deferred finance
costs of approximately $135,000 and (ii) interest on convertible notes of
approximately $240,000. Drew's losses from operations from the measurement date
(October 1998) to the date of sale (March 4, 1999) are dererred and then netted
against the gain on the sale of Drew in thequarter ended March 31, 1999. The
Company estimates that its 33.3% share of such losses of Drew for the period of
October 1998 through March 4, 1999 exceeds $400,000 based upon information
provided by Drew. The reader is referred for further information regarding the
losses generated from these discontinued operations to Notes 3 and 6 to the
Condensed Consolidated Financial Statements.
These businesses were discontinued because, among other things,: (1) the
Company could not service and/or refinance the debt related to the acquisition
of Drew, (2) ECSD did not generate operating profits for the Company and (3)
HCAD required capital which the Company could not obtain on favorable terms.
Ongoing selling, general and administrative costs - Selling, general and
administrative costs decreased from approximately $568,000 in the three months
ended March 31, 1998 to approximately $228,000 in the three months ended March
31, 1999. The March 1998 amounts include accruals of approximately $140,000
which were reversed in the second quarter of 1998. The remaining decrease from
1998 to 1999 reflects significantly decreased costs associated with the
Company's business plans subsequent to the decision to sell Drew. Such costs
have been decreasing since approximately the third quarter of 1998 as the
completion of the plan to sell Drew reduces the need for certain management and
administrative personnel and facilities and other costs. The Company's plan is
to further reduce such costs in 1999 as the sale of Drew is completed and until
new financing or strategic business arrangements are completed.
Research and development costs - In the three months ended March 31, 1998,
research and development costs consisted principally of costs associated with
the Company's development of an alpha prototype of a "microvalve" in
collaboration with a third party, MCNC, for potential use in its "ISTX"
technology. Such costs and related development expenditures decreased to
approximately $45,000, for the three months ended March 31, 1999 due to the
Company's financial position and the effect on the stage of development
activities at the time.
License revenues - License revenues consist principally of revenues
received from IST products and have not been significant to date. One Company
licensee, Textron, has launched a new product, in September 1997, utilizing IST
in an automobile seat. Annually, the Company must first deduct a credit due to
Textron before earning any revenues in that year. To date, earned royalties have
not materially exceed the amount of the credit.
Liquidity and Capital Resources
As indicated in the accompanying consolidated financial statements, as of
March 31, 1999, the Company had negative working capital of approximately
($595,000) and negative net worth of approximately ($414,000), and for the three
months then ended had losses from continuing operations of approximately
($275,000) with no revenues. The Company has a development agenda which requires
additional financing. Losses from continuing operations have continued since
March 31, 1999. These factors, among others, indicate that the Company is in
need of significant additional financing and/or a strategic business arrangement
in order to continue its operations through the 1999 fiscal year. The Company
believes that its cash resources at March 31, 1999 are not sufficient to fund
its operations
17
<PAGE>
through the second quarter of 1999, assuming it receives the cooperation of its
creditors, and it will be required to raise additional capital or enter into a
strategic business arrangement in order to continue its planned operations.
The Company's plans include undertaking a development program to
miniaturize and lower the cost of IST applications in the belief that the result
will be a more marketable product than the current IST application. The
development and subsequent marketing is a multi-year project. In order to
miniaturize and lower the cost of IST applications, the Company and MCNC
(founded in 1980 as the Microelectronics Center of North Carolina and now known
simply as MCNC) have completed an alpha prototype of a microvalve component to
control air flow in the IST system. A beta (production ready) version of the
MCNC microvalve would be the subject of further development about which the
Company and MCNC have entered into a non-binding letter of intent. The Company's
ability to perform such further development will be dependent upon its ability
to obtain sufficient financial resources or its ability to enter into a
strategic transaction which would provide the Company the resources to perform
such development. Such further development would involve costs incurred under
arrangements with MCNC as well as costs incurred by the Company. Beyond
development, the Company would require capital to commercialize, market and
sell. The Company's plans are to raise additional financing or enter into a
strategic transaction in order to proceed with the development program. At the
present time, the Company is in discussion with potential sources of additional
financing and with potential candidates for a strategic transaction. No
assurance can be made that such discussions would result in definitive
arrangements. These factors, among others, indicate that in the absence of
additional financing or a strategic business arrangement, the Company does not
have the financial resources to go forward with such further development and to
continue as a going concern.
There can be no assurances that management's plans described in the
preceding paragraph will be realized. The accompanying Condensed Consolidated
Financial Statements do not include any adjustments related to the
recoverability and classification of assets or the amounts and classification of
liabilities that might be necessary should the Company be unable to continue
operations as a going concern.
In March 1999, the Company received approval of the Company's shareholders
to sell the remaining 33.3% of Drew to the holders of the Company's Convertible
Notes. As such, the Convertible Notes were retired in 1999. Such Convertible
Notes had been due on April 14, 1999 and were secured by all of the assets of
the Company (see Note 4 to Condensed Consolidated Financial Statements).
In February 1999, the Company advised the holders of its 8% unsecured
notes that it had passed on the payment of principal and interest in January
1999 and would be unable to make any further payments until a financial or
strategic transaction was concluded. At March 31, 1999, approximately $25,000 of
principal payments plus interest are in arrears.
The reader is directed to Item 5 - Recent Sales of Unregistered Securities
and to Notes 3, 4 and 5 of Notes to Consolidated Financial Statements for a
discussion of financing activities in 1998 and related restructurings including
the recent retirement of the Convertible Notes in exchange for the sale of the
Company's remaining interest in Drew. Also see Item 3 - LEGAL PROCEEDINGS.
The Year 2000 Issue
At the Company's corporate office, information systems are principally
utilized for general accounting and administration. During 1998, the Company
upgraded such system and currently believes it to be Year 2000 compliant.
Factors That May Affect Future Results
The Company's future operating results are dependent on the Company's ability
to: (i) obtain sufficient capital or a strategic business arrangement , which is
required immediately, to fund its continued operations including its development
and commercialization plans, (ii) pay its debts including significant payments
to trade creditors and noteholders which are presently overdue, (iii) successful
completion of development of a lower cost and smaller version of IST (iv)
successful business development and marketing efforts to, assuming completion of
the development effort in (iii) above, increase the number of licensees, and the
commercialization of IST by its licensees, (v) successfully develop the
"Microvalve" and integrate it into IST, (vi) general economic conditions
18
<PAGE>
and
conditions in the financial and technology markets.
PART II. OTHER INFORMATION
Item 1. Legal proceedings
In January 1998, Ulin & Holland Incorporated ("U & H") filed suit against
the Company's then subsidiary, Drew, in United States District Court for the
District of Massachusetts. The suit alleges that U & H was retained in 1992 by
Drew pursuant to which U & H alleges that it is due a fee of not less than
$297,000 in connection with the Company's acquisition of Drew. Drew disputes
this claim. U & H has named the Company as a defendant in this lawsuit.
Subsequent to the Company's divestiture of the majority ownership of Drew, Drew
is responsible for the defense of this matter. In March 1999, the Company was
notified that it is no longer a defendant in that lawsuit.
On or about February 22, 1999, a shareholder derivative action was filed
in United States District Court for the Eastern District of New York in
connection with certain transactions culminating in the sale by the Company to
Impleo, LLC of the Company's interest in Drew. The complaint names all of the
Company's current directors and several former directors as defendants as well
as Impleo, LLC and certain related entities and individuals (collectively, the
"Defendants"). The allegations contained in the complaint challenge the
Defendants' actions in connection with certain transactions, including but not
limited to, (i) the April 14, 1998 restructuring of certain convertible notes;
(ii) the October 1998 sale of 56.7% of Drew to Impleo, LLC; and (iii) the sale
on March 4, 1999 to Impleo, LLC of the Company's remaining 33.3% interest in the
Drew. In addition to seeking recovery on behalf of the Company for certain
allegedly wrongful acts on the part of the Defendants, the complaint seeks,
among other things, to enjoin or set aside any shareholder vote in connection
with a proxy statement filed with the SEC on or about February 1, 1999 pursuant
to which the Company received approval of over 67% of its shareholders to sell
its remaining 33.3% interest in Drew and to block or rescind the sale of any
interests in Drew to Impleo, LLC. The current Directors deny the allegations
concerning any allegedly wrongful actions. The Company intends to answer the
complaint during May 1999.
In October 1998, the Company's HumanCAD Systems Inc. subsidiary filed an
assignment in bankruptcy under the laws of the Province of Ontario, Canada and
Fuller Landau Ltd., 151 Bloor St. West, Toronto, Canada, was appointed receiver
and trustee. Certain creditors of the HumanCAD operations have filed or
threatened to file claims against the Company for the debts of HumanCAD. One
such action was filed by Miller Freeman, Inc. in the Civil Court of City of New
York in the amount of approximately $18,000. The Company intends to vigorously
defend itself in such action, however its ability to do so may be limited by its
financial resources which are currently inadequate (See Form 10-KSB for the year
ended December 31, 1998 including; Consolidated Financial Statements, Report of
Independent Public Accountants and Management's Discussion and Analysis or Plan
of Operations).
Item 2. Changes in Securities and Use of Proceeds
Elimination of securities which are convertible into or exercisable to
purchase common stock of the Company - See Item 6. Exhibits and Reports on Form
8-K as well as Notes 3 and 4 to Condensed Consolidated Financial Statements for
a discussion of the redemption of $2,220,000 original principal amount plus
$805,350 resulting from pay-in-kind interest of 10%/13% Convertible Notes plus
accrued interest from September 19, 1998 and the resultant elimination of the
conversion feature and warrants which were derivative into several million
common shares of the Company.
Sale of Common Stock, subject to "repricing" provisions and Warrants in
April 1998 and the issuance of "repricing" shares in January 1999 - Beginning on
April 14, 1998, the Company commenced a private offering of its common stock and
warrants. The offering generated aggregate proceeds of $2,000,000 for the
purchase of 1,980,198 shares, subject to "repricing" as described below, of
19
<PAGE>
common stock of the Company and warrants to purchase 250,000 shares of common
stock at $2.05 for three years by seven accredited investors as follows:
Common
Common Shares shares
issued before under
Name of purchaser Amount paid "repricing" warrants
- ----------------- ----------- ----------- --------
Balmore Funds S.A $ 850,000 841,584 106,250
Austost Anstalt Schaan $ 750,000 742,574 93,750
Beeston Investments Ltd. $ 200,000 198,020 25,000
Manor Investments $ 100,000 99,010 12,500
Ellis Enterprises $ 50,000 49,505 6,250
East Lane Corporation, Ltd. $ 50,000 49,505 6,250
---------- --------- -------
Totals $2,000,000 1,980,198 250,000
========== ========= =======
The Company agreed to and did register such shares for resale.
The Company agreed that the number of shares issuable to these investors
would be "repriced" pursuant to a schedule initially in two $300,000 increments
and then in seven $200,000 increments on nine occasions commencing with the
effectiveness of a registration statement covering the shares (declared
effective August 13, 1998) and again 60 days later and then in 30 day intervals.
On such dates, the investor would have received the additional number of shares,
if any, that result from the difference between the number of shares actually
issued and the number of shares which would have been issued using a 23%
discount to the market price, as defined, at that time. The operation of this
provision would have resulted in significantly greater number of shares being
issued. The Company agreed not to issue certain financings and has paid a
placement agent a 6.5% fee in connection with the transaction.
In August 1998, 436,047 shares were issued in connection with the
"repricing" provisions and very significant additional shares (estimated to be
in excess of 5,000,000 shares) would be required to be issued in the October,
November and December 1998 "repricing" dates.
On December 24, 1998, the Company and the investors agreed to amend the
subscription agreement with respect to "repricing". The December 24, 1998
amendment has four principal effects as follows: (i) the August, October,
November and December 1998 "repricings" are eliminated in favor of new
"repricings" which began on January 1, 1999, (ii) the discount from market used
to measure the "repricings" was increased from 23% to 27% (iii) a ceiling price
was established of $0.75 per share and (iv) certain penalties under the
agreement were waived. Under the amended agreement, the investors, at their
option, may reprice up to 12 1/2% of the amount invested (an aggregate of
$250,000 based upon the original $2,000,000 invested in April 1998) on the first
of each month beginning with January 1, 1999. Any amounts not "repriced" in any
month may be carried over to any future month without limitation.
In connection with the amendment, the Company was obliged to issue
additional shares to the investors to bring the total shares from 1,980,198
originally invested up to 2,666,667 shares (inclusive of the 436,047 shares
issued in August 1998 as discussed in the second preceding paragraph) based upon
the $0.75 ceiling price in the amendment. Additionally, these investors
requested a "repricing" of $190,000 of the offering in January 1999. The January
"repricing" and the issuance of the new shares to reflect the
20
<PAGE>
new ceiling resulted in the issuance to the investors of an additional 2,259,827
shares on January 27, 1999.
Of the total dollar amount of the offering, only this $190,000 of the
$2,000,000 proceeds of the offering has been "repriced" leaving $1,810,000 still
to be "repriced" at the holders option. The "repricing" of this amount
($1,810,000) at market prices for the Company's stock in March 1999 would result
in a very significant number of additional shares being issued and in a change
of control of the Company to these investors. The Company is in discussions with
the representatives of the investors to restructure the "repricing" provisions
in light of the very significant effects which would result at current prices of
the Company's common stock.
Item 4. Submission of matters to a vote of security holders At a March 4,
1999 Special Meeting of Shareholders, the following matter was brought for a
vote of the shareholders:
Proposal Votes For Votes Against Abstain
-------- --------- ------------- -------
- --------------------------------------------------------------------------------
1. Proposal to sell the Company's 15,748,202 253,240 7,850
remaining 33.3% common stock interest
in Drew Shoe Corporation to the holder
of the Company's 10/13% Convertible Notes
The proposal required a vote of 66.7% of the shareholders for passage and
the proposal was passed by a vote of approximately 67.7% of the 23,251,116
shares outstanding on January 27, 1999, the date of record.
Item 6. Exhibits and Reports on Form 8-K
(a) Exhibits.
27 Financial Data Schedule.
(b) Reports on Form 8-K
During the period covered by this Report, and through the date of this
report, the Company filed a report on Form 8-K or 8-K/A to report the following
events:
1 A report on December 22, 1998, as amended on January 7, 1999, reporting
that the Company had replaced its auditors, Ernst & Young LLP with J.H.
Cohn LLP and that Drew Shoe Corporation had replaced Ernst & Young LLP
with Hays & Company LLP.
2 A report on January 11, 1999 reporting the restructuring of the
subscription agreement with the investors in the April 1998 private
placement of common stock and warrants with respect to the "repricing"
provisions.
3 A report on February 26, 1999 reporting that a shareholder had filed a
derivative action lawsuit against the Company and its current and certain
former directors as well as others.
4 A report on March 4, 1999 reporting the vote of over 67.7% of the
shareholders on a proposal to sell the Company's remaining 33.3% interest
in Drew Shoe Corporation.
21
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
BCAM INTERNATIONAL, INC.
Dated: May 14, 1999 By: /s/ Michael Strauss
------------ ------------------------------------
Michael Strauss
Chairman of the Board of Directors,
President and Chief Executive Officer
(principal executive officer)
22
<PAGE>
INDEX OF EXHIBITS
Exhibit No. Exhibit
- ----------- -------
27 Financial Data Schedule
23
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> MAR-31-1999
<PERIOD-START> JAN-01-1999
<PERIOD-END> MAR-31-1999
<CASH> 205,000
<SECURITIES> 0
<RECEIVABLES> 0
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 246,000
<PP&E> 0
<DEPRECIATION> 0
<TOTAL-ASSETS> 425,000
<CURRENT-LIABILITIES> 839,000
<BONDS> 0
0
0
<COMMON> 241,000
<OTHER-SE> (170,000)
<TOTAL-LIABILITY-AND-EQUITY> 425,000
<SALES> 0
<TOTAL-REVENUES> 0
<CGS> 0
<TOTAL-COSTS> 273,000
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 2,000
<INCOME-PRETAX> 722,000
<INCOME-TAX> 0
<INCOME-CONTINUING> (275,000)
<DISCONTINUED> 997,000
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 722,000
<EPS-PRIMARY> 0.03
<EPS-DILUTED> 0.03
</TABLE>
